Thursday, December 12, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine

BARDA Awards .27 Million Contract to Evaluate Oral Pill COVID Vaccine

Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb clinical trial to evaluate the company’s oral pill XXB COVID-19 vaccine candidate. The trial is expected to involve 10,000 participants and will […]

Search in Site

To search in site, type your keyword and hit enter

Search